RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Roche Holding EBIT 2024

Roche Holding EBIT

19.83 B CHF

Roche Holding Dividend yield

4.28 %

Ticker

ROG.SW

ISIN

CH0012032048

WKN

855167

In 2024, Roche Holding's EBIT was 19.83 B CHF, a 3.29% increase from the 19.2 B CHF EBIT recorded in the previous year.

The Roche Holding EBIT history

YEAREBIT (undefined CHF)
2029e-
2028e25.29
2027e23.93
2026e22.81
2025e21.48
2024e19.83
202319.2
202220.05
202118.53
202018.97
201920.23
201818.71
201716.92
201616.93
201516.06
201416.98
201317.39
201216.66
201114.61
201013.49
200912.28
200813.9
200714.47
200611.73
20058.78
20046.19

Roche Holding Aktienanalyse

What does Roche Holding do?

Roche Holding AG is a Swiss company that operates in the pharmaceutical and diagnostics sectors. It was founded in Basel in 1896 by Fritz Hoffmann-La Roche and is now one of the largest pharmaceutical companies in the world. The business model of Roche is based on research, development, and distribution of innovative medications and diagnostics for the early detection, diagnosis, and treatment of diseases. Its customers include doctors, hospitals, and laboratories. Roche has three operating divisions: Pharma, Diagnostics, and Genentech. The Pharma division is responsible for the development and marketing of prescription drugs, the Diagnostics division offers a wide range of products for disease diagnosis, and the Genentech division focuses on the development of biotechnological drugs. Roche is known for its strong research investments in new medications and has played a significant role in the history of drug development. The company employs approximately 94,000 people worldwide and is listed on the Swiss stock exchange (SIX: ROG). Some of its well-known products include the cancer drug Avastin, the multiple sclerosis drug Ocrevus, and the diabetes medication RoActemra. Roche is also known for its innovative diagnostic products and has developed numerous tests for disease detection. In recent years, the company has expanded its activities into new therapy areas such as immunotherapy and gene therapy, and it has a strong pipeline of new medications and diagnostics that will be launched in the coming years. Overall, Roche has played a significant role in drug development and diagnostics since its inception, and with its research investments and diverse product portfolio, it will continue to play an important role in the healthcare industry. Roche Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Roche Holding's EBIT

Roche Holding's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Roche Holding's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Roche Holding's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Roche Holding’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Roche Holding Stock

How much did Roche Holding achieve in EBIT for the current year?

In the current year, Roche Holding has achieved an EBIT of 19.83 B CHF.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Roche Holding.

How has the EBIT of Roche Holding developed in recent years?

The EBIT of Roche Holding has increased by 3.287% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Roche Holding?

The EBIT of Roche Holding is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Roche Holding pay?

Over the past 12 months, Roche Holding paid a dividend of 9.5 CHF . This corresponds to a dividend yield of about 4.28 %. For the coming 12 months, Roche Holding is expected to pay a dividend of 11.25 CHF.

What is the dividend yield of Roche Holding?

The current dividend yield of Roche Holding is 4.28 %.

When does Roche Holding pay dividends?

Roche Holding pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Roche Holding?

Roche Holding paid dividends every year for the past 37 years.

What is the dividend of Roche Holding?

For the upcoming 12 months, dividends amounting to 11.25 CHF are expected. This corresponds to a dividend yield of 5.07 %.

In which sector is Roche Holding located?

Roche Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Roche Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Roche Holding from 3/18/2024 amounting to 9.6 CHF, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.

When did Roche Holding pay the last dividend?

The last dividend was paid out on 3/18/2024.

What was the dividend of Roche Holding in the year 2023?

In the year 2023, Roche Holding distributed 9.3 CHF as dividends.

In which currency does Roche Holding pay out the dividend?

The dividends of Roche Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Roche Holding

Our stock analysis for Roche Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Roche Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.